Results 201 to 210 of about 286,924 (257)

Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future

Nature reviews. Urology, 2022
H. Van Poppel, T. Albreht, P. Basu, R. Hogenhout, Sarah Collen, M. Roobol   +5 more
semanticscholar   +1 more source

PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

Urology, 1999
To enhance the specificity of prostate cancer (PCa) detection and reduce unnecessary biopsies in men with prostate-specific antigen (PSA) levels of 2.5 to 4.0 ng/mL, we prospectively evaluated various PSA-based diagnostic parameters.This study included 273 consecutive men with serum PSA of 2.5 to 4.0 ng/mL referred for early PCa detection or lower ...
B, Djavan, A, Zlotta, C, Kratzik, M, Remzi, C, Seitz, C C, Schulman, M, Marberger   +6 more
openaire   +2 more sources

Time to Nadir PSA

American Journal of Clinical Oncology, 2015
The objective of the study was to investigate prostate-specific antigen (PSA) nadir (nPSA) and time to nPSA (TnPSA) as prognostic variables for outcomes after definitive high-dose (>75 Gy) external beam radiation therapy (RT) without androgen deprivation therapy while correcting for immortal-time bias.nPSA and TnPSA were available for 410 patients ...
Skyler B, Johnson, William C, Jackson, Jure, Murgic, Felix Y, Feng, Daniel A, Hamstra   +4 more
openaire   +2 more sources

Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when?

Urology, 2000
To ascertain when the serum determination of the free prostate-specific antigen (PSA)/total PSA (fPSA/tPSA) ratio is clinically useful, and whether the identification of PSA or prostate-specific membrane antigen (PSM) mRNA in circulating cells has diagnostic advantages over the determination of their protein product.fPSA, tPSA, and the fPSA/tPSA ratio ...
BASSO, DANIELA, FOGAR, PAOLA, M. G. Piva, F. Navaglia, S. Mazza, T. Prayer Galetti, E. Castellucci, PAGANO, FRANCESCO, PLEBANI, MARIO   +8 more
openaire   +2 more sources

Standardization of PSA determinations

Scandinavian Journal of Clinical and Laboratory Investigation, 1995
Standardization of determinations for prostate specific antigen (PSA) has become an important issue due to the widespread use of these determinations for prostate cancer screening. Standardization of this assay is complicated due to the occurrence of two major forms of PSA in serum, the free antigen and a complex between PSA and alpha 1 ...
U H, Stenman, J, Leinonen, W M, Zhang
openaire   +2 more sources

Natural history of progression after PSA elevation following radical prostatectomy.

Journal of the American Medical Association (JAMA), 1999
C. Pound, A. Partin, M. Eisenberger, Daniel W. Chan, J. Pearson, P. Walsh   +5 more
semanticscholar   +1 more source

68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour

European Journal of Nuclear Medicine and Molecular Imaging, 2017
C. Uprimny, A. Kroiss, C. Decristoforo, J. Fritz, E. von Guggenberg, D. Kendler, L. Scarpa, Gianpaolo di Santo, Llanos Geraldo Roig, Johanna Maffey-Steffan, W. Horninger, I. Virgolini   +11 more
semanticscholar   +1 more source

Efforts for Improving the Efficiency of PSA: PSA Density, PSA Velocity, Age-specific PSA, and Free and Complexed PSA

Türk Üroloji Seminerleri/Turkish Urology Seminars, 2013
Omer Kutlu, Ismail Turker Koksal
openaire   +1 more source

Impedimetric aptamer-based glycan PSA score for discrimination of prostate cancer from other prostate diseases

Biosensors and Bioelectronics, 2021
Ana Díaz-Fernández, Rebeca Miranda-Castro, Noémi De-Los-Santos-Álvarez   +2 more
exaly  

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

Prostate Cancer and Prostatic Diseases, 2017
T. Nordström, O. Akre, M. Aly, H. Grönberg, M. Eklund   +4 more
semanticscholar   +1 more source